Franklin Street Advisors’s Trinity Biotech TRIB Stock Holding History

Franklin Street Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-107	Closed	-$182K	–	191
2016 Q2	$182K	Sell	107 -61	-36%	-$103K	0.03%	184
2016 Q1	$294K	Buy	168 +36	+27%	+$57.3K	0.06%	180
2015 Q4	$232K	Buy	132 +17	+15%	+$30.1K	0.05%	198
2015 Q3	$197K	Buy	115 +9	+8%	+$21.7K	0.04%	206
2015 Q2	$287K	Hold	106	–	–	0.05%	188
2015 Q1	$306K	Buy	106 +26	+33%	+$72.1K	0.06%	172
2014 Q4	$209K	Sell	80 -132	-62%	-$341K	0.04%	186
2014 Q3	$581K	Buy	212 +4	+2%	+$13K	0.11%	151
2014 Q2	$719K	Buy	208 +39	+23%	+$139K	0.14%	143
2014 Q1	$615K	Buy	169 +21	+14%	+$82.6K	0.12%	157
2013 Q4	$557K	Buy	+148	New	+$533K	0.11%	158

Other funds holding TRIB

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

AAM

ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

LAM

Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Franklin Street Advisors's TRIB Position: Q3 2016 in Review

Franklin Street Advisors sold out of Trinity Biotech (TRIB) in Q3 2016, closing a stake of 107 shares — an estimated $182K sold.

Franklin Street Advisors first reported a position in TRIB in Q4 2013 and held it in 11 quarters. The position peaked at $719K in Q2 2014. 79 funds tracked by Wall St. Rank hold TRIB as of Q3 2016.

Franklin Street Advisors reported no remaining Trinity Biotech position as of Q3 2016 after selling out during the quarter.
Franklin Street Advisors sold 107 Trinity Biotech shares in Q3 2016, an estimated $182K.
Franklin Street Advisors first reported a position in Trinity Biotech in Q4 2013 and held it in 11 quarters.
Franklin Street Advisors's Trinity Biotech position peaked at $719K in Q2 2014.
79 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2016.

Based on Franklin Street Advisors's 13F filing for Q3 2016, filed 5 Oct 2016.